Aimee Raleigh

Principal

2023 - Current

Senior Associate

2022 - 2023

Associate

2020 - 2022

Life Sciences Consultant

2020 - 2020

Senior Life Sciences Specialist

2019 - 2020

• 15+ engagements across therapeutics and tools / diagnostics with a focus on growth strategy and M&A, including both buy- and sell-side diligences • Present regularly to C-suite executives and manage teams of 1 – 3 • Serve as Head of the Los Angeles office Women’s Network and member of Community Impact Committee Selected transactions include: - Forecast revenue and total addressable market for a global electron microscopy camera supplier to inform a ~$500M potential acquisition, including growth drivers and sensitivity analysis - Evaluated opportunity size and indication expansion strategy for a commercialized bladder cancer Tx - Forecast market size and company revenue for a bioprocessing manufacturer to inform a ~$50M LBO, including market growth, competitor landscape, and customer evaluation - Advised on $5B partnership expansion for a large global biotech (developed revenue forecasts for key pipeline assets and analyzed peak sales scenarios and sensitivities to price and order of market entry) - Evaluated market opportunity, product revenue potential, technical differentiators, competitive landscape, and acquisition deal term comparables for a preclinical CAR-T asset - Forecast total U.S. hospice market and revenue for a national for-profit player, including analysis of key growth drivers and competitive landscape - Supported diligence screen on 100+ late-phase oncology assets based on portfolio fit, clinical feasibility, and peak revenue opportunity

Life Sciences Specialist

2018 - 2019

Graduate Researcher

2013 - 2018

- Accepted into Gordon Graduate Scholars Program Spring 2015 - Awarded UCSD Frontiers of Innovation Scholarship (FISP) in January 2015 - Awarded Translational Musculoskeletal Research training grant (T32) in Fall 2014 - Coordinated animal study to evaluate the effect of post-traumatic osteoarthritis on key metrics of joint health; directed a team of 5 undergraduates and staff scientists (held weekly progress meetings, coordinated experiments, wrote reports, and summarized findings); project resulted in 2 pending first author presentations and 3 global conference posters and oral presentations TA for the following classes: - BENG 186A (Principals of Biomaterials Design, Undergraduate Level), - BENG 277 (Tissue Engineering Laboratory, Graduate Level) - BENG 241A (Tissue Engineering, Graduate Level)

Co-Founder

2012 - 2014

LuxSano is a company founded on the innovative combination of Ultraviolet C light and pulsatile lavage. We have received funding from the NCIIA E-Team Program and made it to the top 10 finalist round of the Duke StartUp Challenge.

Innovation Associate

2013 - 2013

Helped to manage and grow portfolio of medical device patents; responded to USPTO Office Actions to improve IP coverage.

Undergraduate Researcher in the Reichert Lab

2012 - 2013

Monitored B lymphocyte migration on chemokine gradients, developed tracking protocols in Imaris

Molecular Separations Intern

2012 - 2012

Developed testing procedures to assess efficiency of both IEX and HILIC chromatography media. Used van Deemter parameters and H-U curves to determine standards of performance.

LC/MS Intern

2011 - 2011

Used Biacore to model protein-protein binding between various glycoforms and lectins.

Intern

2010 - 2010

Worked on patent development for biomedical devices and assisted in finance management.

Intern

2009 - 2009

Served as a Quality Assurance tester for new software